Publications
Detailed Information
Expression of Vascular Endothelial Growth Factor and Hypoxia Inducible Factor-1α in Cervical Neoplasia
DC Field | Value | Language |
---|---|---|
dc.contributor.author | No, Jae Hong | - |
dc.contributor.author | Jo, Hoenil | - |
dc.contributor.author | Kim, Su-Hyeong | - |
dc.contributor.author | Park, In-Ae | - |
dc.contributor.author | Han, Seung-Su | - |
dc.contributor.author | Park, Noh-Hyun | - |
dc.contributor.author | Song, Yong-Sang | - |
dc.contributor.author | Kang, Soon-Beorn | - |
dc.contributor.author | Kim, Jae Weon | - |
dc.contributor.author | Kang, Daehee | - |
dc.date.accessioned | 2012-06-04T02:08:26Z | - |
dc.date.available | 2012-06-04T02:08:26Z | - |
dc.date.issued | 2009 | - |
dc.identifier.citation | NATURAL COMPOUNDS AND THEIR ROLE IN APOPTOTIC CELL SIGNALING PATHWAYS: Ann. N.Y. Acad. Sci.; Vol.1171 ; 105-110 | ko_KR |
dc.identifier.issn | 0077-8923 | - |
dc.identifier.uri | https://hdl.handle.net/10371/76756 | - |
dc.description.abstract | Altered angiogenesis is an important phenotype of high-grade cervical lesions and invasive cervical carcinomas. Many researchers, including us, have shown that oncoproteins of human papillomavirus could enhance the vascular endothelial growth factor (VEGF) expression. We investigated the change in VEGF and hypoxia-inducible factor-1 alpha (HIF-1 alpha) expression patterns that occur during the carcinogenesis and progression of cervical cancer. Expressions of HIF-1 alpha and VEGF were evaluated by immunohistochemistry using paraffin-embedded specimens obtained from 41 patients with a normal cervix, 39 patients with cervical intraepithelial neoplasia (CIN 1, 10; CIN 2/3, 29), and 36 patients with cervical cancer. The VEGF and HIF-1 alpha expressions were higher in CIN and invasive cancer than in normal cervix (P = 0.021, P < 0.001, respectively). It is interesting to note that there was no significant difference in VEGF and HIF-1 alpha overexpressions between CIN 2/3 and cervical cancer and between nonmetastatic and metastatic cancers. In addition, there was a significant correlation between the immunohistochemical score of HIF-1 alpha and that of VEGF expression (Spearman`s correlation coefficient 0.275, P = 0.003, n = 116). Taken together, the results of our study suggest that expressions of VEGF and HIF-1 alpha could be involved in cervical carcinogenesis. In addition, the weak correlation between VEGF and HIF-1 alpha expressions suggests that regulatory mechanisms other than HIF-1 alpha may be involved in the expression of VEGF during cervical carcinogenesis. | ko_KR |
dc.language.iso | en | ko_KR |
dc.publisher | BLACKWELL PUBLISHING | ko_KR |
dc.subject | cervical neoplasia | ko_KR |
dc.subject | HIF-1α | ko_KR |
dc.subject | VEGF | ko_KR |
dc.title | Expression of Vascular Endothelial Growth Factor and Hypoxia Inducible Factor-1α in Cervical Neoplasia | ko_KR |
dc.type | Article | ko_KR |
dc.contributor.AlternativeAuthor | 노재홍 | - |
dc.contributor.AlternativeAuthor | 조헌일 | - |
dc.contributor.AlternativeAuthor | 김수형 | - |
dc.contributor.AlternativeAuthor | 박인애 | - |
dc.contributor.AlternativeAuthor | 강대희 | - |
dc.contributor.AlternativeAuthor | 한승수 | - |
dc.contributor.AlternativeAuthor | 김재원 | - |
dc.contributor.AlternativeAuthor | 박노현 | - |
dc.contributor.AlternativeAuthor | 강순범 | - |
dc.contributor.AlternativeAuthor | 송용상 | - |
dc.identifier.doi | 10.1111/j.1749-6632.2009.04891.x | - |
dc.citation.journaltitle | NATURAL COMPOUNDS AND THEIR ROLE IN APOPTOTIC CELL SIGNALING PATHWAYS | - |
dc.description.citedreference | Lee WY, 2008, GYNECOL ONCOL, V108, P377, DOI 10.1016/j.ygyno.2007.10.034 | - |
dc.description.citedreference | Roskoski R, 2007, CRIT REV ONCOL HEMAT, V62, P179, DOI 10.1016/j.critrevonc.2007.01.006 | - |
dc.description.citedreference | Liao D, 2007, CANCER METAST REV, V26, P281, DOI 10.1007/s10555-007-9066-y | - |
dc.description.citedreference | Song SH, 2006, INT J GYNECOL CANCER, V16, P2009, DOI 10.1111/j.1525-1438.2006.00727.x | - |
dc.description.citedreference | Fujimoto J, 2006, CANCER SCI, V97, P861, DOI 10.1111/j.1349-7006.2006.0262.x | - |
dc.description.citedreference | Kim SH, 2006, CELL MOL LIFE SCI, V63, P930, DOI 10.1007/s00018-005-5561-x | - |
dc.description.citedreference | Triratanachat S, 2006, INT J GYNECOL CANCER, V16, P575 | - |
dc.description.citedreference | Rasila KK, 2005, INT J GYNECOL CANCER, V15, P710 | - |
dc.description.citedreference | Hutchison GJ, 2004, CLIN CANCER RES, V10, P8405 | - |
dc.description.citedreference | Mayer A, 2004, CANCER RES, V64, P5876 | - |
dc.description.citedreference | Lee JS, 2003, ANAL QUANT CYTOL, V25, P303 | - |
dc.description.citedreference | Van Trappen PO, 2003, J PATHOL, V201, P544, DOI 10.1002/path.1467 | - |
dc.description.citedreference | Semenza GL, 2003, NAT REV CANCER, V3, P721, DOI 10.1038/nrc1187 | - |
dc.description.citedreference | Acs G, 2003, AM J PATHOL, V162, P1789 | - |
dc.description.citedreference | Birner P, 2000, CANCER RES, V60, P4693 | - |
dc.description.citedreference | Dobbs SP, 1997, BRIT J CANCER, V76, P1410 | - |
dc.description.citedreference | Obermair A, 1997, J NATL CANCER I, V89, P1212 | - |
dc.description.citedreference | GUIDI AJ, 1995, J NATL CANCER I, V87, P1237 | - |
dc.description.tc | 5 | - |
- Appears in Collections:
- Files in This Item:
- There are no files associated with this item.
Item View & Download Count
Items in S-Space are protected by copyright, with all rights reserved, unless otherwise indicated.